- Home
- UFI vs INMB Comparison
UFI vs INMB Comparison
Compare UFI & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFI
- INMB
- Stock Information
- Founded
- UFI 1969
- INMB 2015
- Country
- UFI United States
- INMB United States
- Employees
- UFI N/A
- INMB N/A
- Industry
- UFI Textiles
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- UFI Consumer Discretionary
- INMB Health Care
- Exchange
- UFI Nasdaq
- INMB Nasdaq
- Market Cap
- UFI 123.0M
- INMB 123.0M
- IPO Year
- UFI N/A
- INMB 2019
- Fundamental
- Price
- UFI $6.93
- INMB $5.14
- Analyst Decision
- UFI
- INMB Buy
- Analyst Count
- UFI 0
- INMB 1
- Target Price
- UFI N/A
- INMB $22.00
- AVG Volume (30 Days)
- UFI 56.7K
- INMB 371.2K
- Earning Date
- UFI 10-30-2024
- INMB 10-30-2024
- Dividend Yield
- UFI N/A
- INMB N/A
- EPS Growth
- UFI N/A
- INMB N/A
- EPS
- UFI N/A
- INMB N/A
- Revenue
- UFI $582,209,000.00
- INMB $85,000.00
- Revenue This Year
- UFI $16.88
- INMB N/A
- Revenue Next Year
- UFI $3.10
- INMB N/A
- P/E Ratio
- UFI N/A
- INMB N/A
- Revenue Growth
- UFI N/A
- INMB N/A
- 52 Week Low
- UFI $5.41
- INMB $4.81
- 52 Week High
- UFI $7.91
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- UFI 51.53
- INMB 40.74
- Support Level
- UFI $6.64
- INMB $4.87
- Resistance Level
- UFI $7.04
- INMB $5.73
- Average True Range (ATR)
- UFI 0.30
- INMB 0.29
- MACD
- UFI -0.05
- INMB 0.05
- Stochastic Oscillator
- UFI 48.06
- INMB 35.29
About UFI Unifi Inc. New
Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.